Skip to main content
Glama

get_bioactivity_assay

get_bioactivity_assay
Read-onlyIdempotent

Retrieve assay annotations or lists by AEID, gene, single-concentration, or all from EPA CompTox bioactivity data.

Instructions

Retrieve assay annotations or lists (by AEID, gene, single-concentration, or all)

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
aeidNoAssay endpoint ID (required for aeid and single-concentration modes)
modeYesAssay query type
gene_symbolNoGene symbol (required for gene mode)

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault
dataYesAssay annotation payload returned for all-assay, single AEID, single-concentration, or gene-scoped bioactivity assay queries.

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observedv0.3.0

TDQS

B3.4/5.0
Behavior2/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, openWorldHint, and destructiveHint=false. The description adds no additional behavioral context such as rate limits, authentication requirements, or response behavior beyond what the annotations and schema already convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

A single front-loaded sentence with no wasted words. It immediately states the action, the resource, and the available query dimensions.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With an output schema and rich annotations already present, the description only needs to cover purpose and invocation context. It does so adequately by naming the retrieval targets and modes, though it could better distinguish this tool from its batch and list-oriented siblings.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents aeid, mode, and gene_symbol. The description names the same modes but adds no extra syntax, format, or constraint information beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb ('Retrieve') and resource ('assay annotations or lists'), and lists the query modes. It does not explicitly distinguish itself from close siblings such as batch_get_bioactivity_assay_annotations or get_bioactivity_assay_chemicals, but the purpose is clear enough to select the tool.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The modes ('by AEID, gene, single-concentration, or all') imply when each query path applies, but the description never states when to use this tool versus the batch annotation, count, or chemical-list siblings. Usage is implied rather than guided.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Deploy Server

Other Tools